Metrics of HIV Pre-exposure Prophylaxis (PrEP) Implementation Before and After a Multidisciplinary Task Force at an Academic Institution

Background and Objectives: There is a paucity of guidance on HIV pre-exposure prophylaxis (PrEP) implementation in an academic medical center. The objectives of this study were to describe interventions by a multidisciplinary PrEP task force at an academic medical center and compare metrics of PrEP implementation pre- and post-creation of this entity. Methods: The interventions of the task force are described within the rubric of the PrEP care continuum. Participants were adults prescribed PrEP for greater than or equal to 30 days at 9 clinical sites across a university health system. Metrics of PrEP implementation were compared over 12-month intervals before and after the creation of the task force. Results: An increased proportion of participants had HIV testing within 7 days of new PrEP prescriptions (92% vs 63%, P < .001) and were prescribed PrEP in increments of 90 days or shorter (74% vs 56%, P < .001) after the creation of the task force. There were higher rates of testing for bacterial sexually transmitted infections in men who had sex with men and transgender women in the post-intervention compared with pre-intervention period. Conclusions: A multidisciplinary team that focuses on optimizing PrEP delivery along each step of the care continuum may facilitate PrEP scale-up and best practices in an academic setting.

[1]  T. Kirby.  Cabotegravir, a new option for PrEP. , 2020, Lancet. Infectious Diseases (Print).

[2]  V. Patel,et al.  Preferences for implementation of HIV pre-exposure prophylaxis (PrEP): Results from a survey of primary care providers , 2019, Preventive medicine reports.

[3]  A. Zuppa,et al.  Tenofovir urine assay to monitor adherence to HIV pre-exposure prophylaxis (PrEP). , 2019, Current clinical pharmacology.

[4]  S. Little,et al.  GrindrTM Users Take more Risks, but are more Open to HIV Pre-Exposure Prophylaxis: Could this Dating App Provide Platform for HIV Prevention Outreach? , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  M. Stein,et al.  Racial and Ethnic Disparities in HIV Pre-exposure Prophylaxis Awareness Among Men Who have Sex with Men , 2019, AIDS and Behavior.

[6]  Emma C Spencer,et al.  Racial/Ethnic Disparities in HIV Preexposure Prophylaxis Among Men Who Have Sex with Men — 23 Urban Areas, 2017 , 2019, MMWR. Morbidity and mortality weekly report.

[7]  C. Udeagu,et al.  Ongoing Disparities in Prediagnosis Preexposure Prophylaxis Use Among Persons Recently Diagnosed With HIV in New York City, 2015-2017. , 2019, American Journal of Public Health.

[8]  E. Gardner,et al.  Same-Day HIV Pre-Exposure Prophylaxis (PrEP) Initiation During Drop-in Sexually Transmitted Diseases Clinic Appointments Is a Highly Acceptable, Feasible, and Safe Model that Engages Individuals at Risk for HIV into PrEP Care , 2019, Open forum infectious diseases.

[9]  D. Krakower,et al.  Update on HIV Preexposure Prophylaxis: Effectiveness, Drug Resistance, and Risk Compensation , 2019, Current Infectious Disease Reports.

[10]  P. Sullivan,et al.  Implementation Strategies to Increase PrEP Uptake in the South , 2019, Current HIV/AIDS Reports.

[11]  D. Krakower,et al.  Drug Resistance During HIV Pre-Exposure Prophylaxis , 2019, Drugs.

[12]  B. Wood,et al.  A Review of Telehealth Innovations for HIV Pre-Exposure Prophylaxis (PrEP) , 2019, Current HIV/AIDS Reports.

[13]  A. Hatzakis,et al.  Pre-exposure Prophylaxis (PrEP) Awareness and Use Within High HIV Transmission Networks , 2019, AIDS and Behavior.

[14]  J. Volk,et al.  Barriers to preexposure prophylaxis use among individuals with recently acquired HIV infection in Northern California , 2018, AIDS care.

[15]  D. Klepser,et al.  Acceptability and Feasibility of a Pharmacist-Led Human Immunodeficiency Virus Pre-Exposure Prophylaxis Program in the Midwestern United States , 2018, Open forum infectious diseases.

[16]  E. Vittinghoff,et al.  Brief Report: A Panel Management and Patient Navigation Intervention Is Associated With Earlier PrEP Initiation in a Safety-Net Primary Care Health System , 2018, Journal of acquired immune deficiency syndromes.

[17]  R. Stall,et al.  Elevated HIV Prevalence and Correlates of PrEP Use Among a Community Sample of Black Men Who Have Sex With Men , 2018, Journal of acquired immune deficiency syndromes.

[18]  E. Petersen,et al.  Overcoming 'purview paradox' to make way for the effective implementation of PrEP in preventing HIV transmission. , 2018, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[19]  Sarah J. Newman,et al.  PrEP implementation by local health departments in US cities and counties: Findings from a 2015 assessment of local health departments , 2018, PloS one.

[20]  W. Powderly,et al.  Missed Opportunities to Prescribe HIV Pre-Exposure Prophylaxis by Primary Care Providers in Saint Louis, Missouri. , 2018, LGBT health.

[21]  E. Vittinghoff,et al.  Provider Adherence to Pre-exposure Prophylaxis Monitoring Guidelines in a Large Primary Care Network , 2018, Open forum infectious diseases.

[22]  M. Friend,et al.  Estimated HIV incidence and prevalence in the United States 2010–2015 , 2018 .

[23]  Beth Berrean,et al.  A Simple Pre-Exposure Prophylaxis (PrEP) Optimization Intervention for Health Care Providers Prescribing PrEP: Pilot Study , 2018, JMIR formative research.

[24]  D. Vlahov,et al.  HIV Pre-exposure Prophylaxis (PrEP) Uptake and Retention Among Men Who Have Sex with Men in a Community-Based Sexual Health Clinic , 2018, AIDS and Behavior.

[25]  V. Patel,et al.  The Use of Online Posts to Identify Barriers to and Facilitators of HIV Pre-exposure Prophylaxis (PrEP) Among Men Who Have Sex with Men: A Comparison to a Systematic Review of the Peer-Reviewed Literature , 2018, AIDS and Behavior.

[26]  M. Mimiaga,et al.  Defining the HIV pre-exposure prophylaxis care continuum , 2017, AIDS.

[27]  I. Bogoch,et al.  Transitioning to HIV Pre-Exposure Prophylaxis (PrEP) from Non-Occupational Post-Exposure Prophylaxis (nPEP) in a Comprehensive HIV Prevention Clinic: A Prospective Cohort Study. , 2015, AIDS patient care and STDs.

[28]  R. Street,et al.  Provider Beliefs and Practices About Assessing Sexual Orientation in Two Veterans Health Affairs Hospitals. , 2014, LGBT health.

[29]  K. Mayer,et al.  HIV Providers’ Perceived Barriers and Facilitators to Implementing Pre-exposure Prophylaxis in Care Settings: A Qualitative Study , 2014, AIDS and Behavior.

[30]  James D. Campbell,et al.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. , 2012, The New England journal of medicine.

[31]  David V Glidden,et al.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. , 2010, The New England journal of medicine.